{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:38:22Z","timestamp":1776098302468,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002642","name":"Korea University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002642","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.prro.2024.09.008","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T02:14:42Z","timestamp":1728526482000},"page":"e155-e165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radiation Therapy Dose for Limited-stage Extranodal Marginal Zone Lymphomas of the Mucosa-associated Lymphoid Tissues of the Stomach: A Meta-analysis"],"prefix":"10.1016","volume":"15","author":[{"given":"Song Heui","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Sook","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka-Won","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9855-3636","authenticated-orcid":false,"given":"Nam Kwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2024.09.008_bib0001","unstructured":"National Comprehensive Cancer Network. B-cell lymphomas (version 2.2024). Updated 2024. Accessed May 3, 2024. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b-cell.pdf"},{"key":"10.1016\/j.prro.2024.09.008_bib0002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO clinical practice guidelines for diagnosis, treatment, and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2024.09.008_bib0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: Field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.09.008_bib0004","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/annonc\/mds623","article-title":"Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: A retrospective, multi-centre, International Extranodal Lymphoma Study Group study","volume":"24","author":"Wirth","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2024.09.008_bib0005","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1182\/bloodadvances.2020003992","article-title":"Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patients","volume":"5","author":"Yahalom","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.prro.2024.09.008_bib0006","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.09.008_bib0007","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): A randomised phase 3 non-inferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2024.09.008_bib0008","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijrobp.2019.02.002","article-title":"Outcomes after reduced-dose intensity modulated radiation therapy for gastric mucosa-associated lymphoid tissue (MALT) lymphoma","volume":"104","author":"Pinnix","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.09.008_bib0009","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00535-018-1517-4","article-title":"Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: A prospective randomized trial","volume":"54","author":"Schmelz","year":"2019","journal-title":"J. Gastroenterol"},{"key":"10.1016\/j.prro.2024.09.008_bib0010","article-title":"Comparable efficacy of reduced dose radiation therapy for the treatment of early stage gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue","volume":"6","author":"Saifi","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2024.09.008_bib0011","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.prro.2024.09.008_bib0012","unstructured":"Wells GA, Shea, B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed November 27, 2023. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm"},{"key":"10.1016\/j.prro.2024.09.008_bib0013","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.prro.2024.09.008_bib0014","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.prro.2024.09.008_bib0015","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.4","article-title":"Chapter 10: Analysing data and undertaking meta-analyses","author":"Deeks","year":"2023"},{"key":"10.1016\/j.prro.2024.09.008_bib0016","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.prro.2024.09.008_bib0017","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jrsm.1140","article-title":"An empirical comparison of heterogeneity variance estimators in 12894 meta-analyses","volume":"6","author":"Langan","year":"2015","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.prro.2024.09.008_bib0018","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"Peters","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2024.09.008_bib0019","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.prro.2024.09.008_bib0020","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3349\/ymj.2002.43.5.601","article-title":"Low grade MALT lymphoma of the stomach: Treatment outcome with radiotherapy alone","volume":"43","author":"Park","year":"2002","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.prro.2024.09.008_bib0021","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/cncr.21152","article-title":"Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment","volume":"104","author":"Nakamura","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2024.09.008_bib0022","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1523-5378.2006.00382.x","article-title":"Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection","volume":"11","author":"Akamatsu","year":"2006","journal-title":"Helicobacter"},{"key":"10.1016\/j.prro.2024.09.008_bib0023","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1445-5994.2006.01291.x","article-title":"Radiotherapy for low-grade gastric marginal zone lymphoma: A retrospective study","volume":"37","author":"Lin","year":"2007","journal-title":"Int Med J"},{"key":"10.1016\/j.prro.2024.09.008_bib0024","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1572-0241.2007.01521.x","article-title":"Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status","volume":"103","author":"Nakamura","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.prro.2024.09.008_bib0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2008.03.012","article-title":"Radiotherapy for 41 patients with stages I and II MALT lymphoma: A retrospective study","volume":"87","author":"Yamashita","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.09.008_bib0026","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2008.12.004","article-title":"Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma","volume":"90","author":"Tomita","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.09.008_bib0027","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","article-title":"Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy","volume":"116","author":"Goda","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2024.09.008_bib0028","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3748\/wjg.v16.i17.2158","article-title":"Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma","volume":"16","author":"Park","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.prro.2024.09.008_bib0029","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000339497","article-title":"A prospective analysis of efficacy and long-term outcome of radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma","volume":"86","author":"Okada","year":"2012","journal-title":"Digestion"},{"key":"10.1016\/j.prro.2024.09.008_bib0030","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.3748\/wjg.v19.i36.6062","article-title":"Clinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma","volume":"19","author":"Kim","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.prro.2024.09.008_bib0031","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/jjco\/hyt097","article-title":"A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy","volume":"43","author":"Abe","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.prro.2024.09.008_bib0032","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5009\/gnl.2014.8.4.408","article-title":"Treatment outcome for gastric mucosa-associated lymphoid tissue lymphoma according to Helicobacter pylori infection status: A single-center experience","volume":"8","author":"Ryu","year":"2014","journal-title":"Gut Liver"},{"key":"10.1016\/j.prro.2024.09.008_bib0033","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2015.08.029","article-title":"Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up","volume":"117","author":"Ruskon\u00e9-Fourmestraux","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.09.008_bib0034","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3857\/roj.2016.01865","article-title":"Radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma: dose-volumetric analysis and its clinical implications","volume":"34","author":"Lim","year":"2016","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.prro.2024.09.008_bib0035","doi-asserted-by":"crossref","first-page":"e471","DOI":"10.1016\/j.prro.2017.03.001","article-title":"Daily CT guidance improves target coverage during definitive radiation therapy for gastric MALT lymphoma","volume":"7","author":"Wang","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2024.09.008_bib0036","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jrr\/rrw044","article-title":"Radiotherapy for localized gastric mucosa-associated lymphoid tissue lymphoma: Long-term outcomes over 10 years","volume":"58","author":"Ohkubo","year":"2017","journal-title":"J Radiat Res"},{"key":"10.1016\/j.prro.2024.09.008_bib0037","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.canrad.2018.02.001","article-title":"[Results of a retrospective study on radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma]","volume":"22","author":"Ghorbal","year":"2018","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.prro.2024.09.008_bib0038","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00066-019-01446-5","article-title":"Favorable radiation field decrease in gastric marginal zone lymphoma: Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL)","volume":"195","author":"Reinartz","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.prro.2024.09.008_bib0039","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13014-020-01649-6","article-title":"Analysis of the response time to involved-field radiotherapy in primary gastrointestinal low-grade B-cell lymphoma","volume":"15","author":"Choi","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2024.09.008_bib0040","doi-asserted-by":"crossref","first-page":"e762","DOI":"10.1016\/j.ijrobp.2020.07.197","article-title":"The treatment results of reduced dose radiotherapy for gastric MALT lymphoma","volume":"108","author":"Inaba","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.09.008_bib0041","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5045\/br.2020.2020174","article-title":"Radiotherapy for non-gastric intestinal versus gastric MALT lymphoma: A comparison of treatment outcomes","volume":"55","author":"Watanabe","year":"2020","journal-title":"Blood Res"},{"key":"10.1016\/j.prro.2024.09.008_bib0042","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3390\/cancers13061390","article-title":"Biophysical analysis of acute and late toxicity of radiotherapy in gastric marginal zone lymphoma-Impact of radiation dose and planning target volume","volume":"13","author":"Reinartz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prro.2024.09.008_bib0043","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/cancers13020169","article-title":"Long-term clinical outcome and predictive factors for relapse after radiation therapy in 145 patients with stage I gastric B-cell lymphoma of mucosa-associated lymphoid tissue type","volume":"13","author":"Nam","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prro.2024.09.008_bib0044","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.21873\/anticanres.16549","article-title":"Outcome of hypofractionated radiotherapy for localized gastric mucosa-associated lymphoid tissue lymphoma","volume":"43","author":"Ochi","year":"2023","journal-title":"Anticancer Res"},{"key":"10.1016\/j.prro.2024.09.008_bib0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/PPO.0000000000000453","article-title":"Radiotherapy for non-Hodgkin lymphomas","volume":"26","author":"Imber","year":"2020","journal-title":"Cancer J"},{"key":"10.1016\/j.prro.2024.09.008_bib0046","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2016.041","article-title":"Limited stage follicular lymphoma: Current role of radiation therapy","volume":"8","author":"Filippi","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.prro.2024.09.008_bib0047","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1470-2045(20)30686-0","article-title":"4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): Long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial","volume":"22","author":"Hoskin","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2024.09.008_bib0048","unstructured":"National Comprehensive Cancer Network. Hodgkin lymphomas (version 3.2024). Updated 2024. Accessed May 3, 2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hodgkins.pdf"},{"key":"10.1016\/j.prro.2024.09.008_bib0049","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijrobp.2012.09.001","article-title":"Second solid cancers after radiation therapy: A systematic review of the epidemiologic studies of the radiation dose-response relationship","volume":"86","author":"Berrington de Gonzalez","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.09.008_bib0050","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1200\/JCO.2000.18.3.498","article-title":"Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment","volume":"18","author":"Swerdlow","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.09.008_bib0051","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/gast.2002.33047","article-title":"T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication","volume":"122","author":"Liu","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prro.2024.09.008_bib0052","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hon.3078","article-title":"Long term outcomes of gastric mucosa-associated lymphoid tissue lymphoma treated with radiotherapy: A multi-center retrospective cohort study","volume":"41","author":"Smith","year":"2023","journal-title":"Hematol Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024002686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024002686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:23:52Z","timestamp":1762561432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850024002686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1879850024002686"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2024.09.008","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy Dose for Limited-stage Extranodal Marginal Zone Lymphomas of the Mucosa-associated Lymphoid Tissues of the Stomach: A Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2024.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}